Tantawi Sana, Issa Elio, Matli Kamal, Farah Raymond, Costanian Christy, Miner Steven, Assaad Shafika, Ghanem Georges
Faculty of Medical Sciences, Lebanese University, Hadath, Beirut, Lebanon.
Gilbert and Rose‑Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
J Echocardiogr. 2024 Dec 28. doi: 10.1007/s12574-024-00677-5.
Left atrial strain (LAS) was recently introduced as a parameter that reflects on left atrial function. Consequently, changes in LAS can inform the development of cardiovascular diseases, hence providing a window for non-invasive and cost-effective testing of these diseases and their complications at early stages of development, potentially offering a segway towards preventive interventions. LAS has yet to be implemented into standard practice. Therefore, we aimed to synthesize the current evidence on the diagnostic and prognostic potentials of LAS in a variety of cardiovascular diseases. We attempted to elucidate sufficient evidence to support uptake into clinical practice. A systematic search of four databases (Medline, PubMed, Embase, CINAHL) was performed for articles published within the last 5 years, for inclusion in this narrative review. A total of 3921 articles were identified, among which only 43 articles were included. LAS showed diagnostic potential in detecting (1) paroxysmal atrial fibrillation in stroke patients, (2) left atrial appendage dysfunction in patients with nonvalvular atrial fibrillation and heart failure with reduced ejection fraction, and finally (3) diastolic dysfunction in patients with arrhythmias, valvulopathies, acute coronary syndrome, primary arterial hypertension, and heart failure. LAS was also prognostic for the development of (1) atrial fibrillation in hypertensive patients, cardiovascular events in patients with (2) valvular diseases and (3) ischemic heart diseases, and (4) heart failure in patients with and without diastolic dysfunction. This review highlights the potential of LAS in identifying certain cardiac pathologies and their repercussions on patient prognosis, which should prompt courageous integration into the clinical workup while emphasizing areas for future research to guarantee successful and safe implementation into clinical practice.
左心房应变(LAS)最近被引入作为反映左心房功能的一个参数。因此,LAS的变化可以为心血管疾病的发展提供信息,从而为这些疾病及其并发症在早期阶段的非侵入性和低成本检测提供一个窗口,有可能为预防性干预提供一个途径。LAS尚未应用于标准实践。因此,我们旨在综合目前关于LAS在各种心血管疾病中的诊断和预后潜力的证据。我们试图阐明足够的证据以支持其在临床实践中的应用。对四个数据库(Medline、PubMed、Embase、CINAHL)进行了系统检索,以查找过去5年内发表的文章,纳入本叙述性综述。共识别出3921篇文章,其中仅纳入43篇。LAS在检测以下情况时显示出诊断潜力:(1)中风患者的阵发性心房颤动;(2)非瓣膜性心房颤动和射血分数降低的心力衰竭患者的左心耳功能障碍;最后(3)心律失常、瓣膜病、急性冠状动脉综合征、原发性高血压和心力衰竭患者的舒张功能障碍。LAS对以下疾病的发生也具有预后价值:(1)高血压患者的心房颤动;(2)瓣膜病患者的心血管事件;(3)缺血性心脏病患者的心血管事件;以及(4)有或无舒张功能障碍的心力衰竭患者的心力衰竭。本综述强调了LAS在识别某些心脏病理及其对患者预后的影响方面的潜力,这应促使其大胆地纳入临床检查,同时强调未来研究的领域,以确保成功且安全地应用于临床实践。